申请人:Heptares Therapeutics Limited
公开号:US20210300906A1
公开(公告)日:2021-09-30
The disclosures herein relate to novel compounds of formula (1): and salts thereof, wherein A; X; n; R
1
and R
2
are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of disorders associated with H4 receptors.